Skip to main content
. 2026 Feb 1;76(763):e163–e174. doi: 10.3399/BJGP.2024.0806

Table 2. The genomic variants included in the secondary analysis and their prevalence in the UKBB.

Gene Variant ID Directly genotyped or imputed Imputation score R 2a Chromosome number Position Allele 1 Allele 2 Minor allele UKBB MAF UKBB (unrelated Europeans)
NAT2 rs1041983 Imputed 0.999 chr8 18 257 795 C T T 0.33
NAT2 rs1799930 Genotyped N/A chr8 18 258 103 G A A 0.30
DPP6 rs6977820 Genotyped N/A chr7 154 072 020 T C T 0.28
COQ2 rs4693075 Genotyped N/A chr4 84 192 168 G C G 0.38
MC4R rs489693 Genotyped N/A chr18 57 882 787 C A A 0.33
GATM rs1346268 Imputed 1 chr15 45 673 029 T C C 0.26
GATM rs1719247 Imputed 0.995 chr15 45 620 985 C T T 0.26
SLCO1B1 rs4149056 Genotyped N/A chr12 21 331 549 T C C 0.15
ANKK1 rs1800497 Genotyped N/A chr11 113 270 828 G A A 0.21
CYP2C9 rs1057910 Genotyped N/A chr10 96 741 053 A C C 0.06
a

R 2 is the squared correlation between input genotypes and imputed dosages (that is, true and inferred genotypes). MAF = minor allele frequency. N/A = not applicable (imputation score applies only to imputed variants). UKBB = UK Biobank.